Jun. 18 at 9:20 PM
MetaVia (Nasdaq:
$MTVA ) presents its dual-agonist obesity candidate DA-1726 and MASH program at the Life Sciences Virtual Investor Forum on June 24 at 10:30 AM ET.
MetaVia Inc. (Nasdaq: MTVA) presents at the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, at 10:30 AM ET on Wednesday, June 24, 2026.
The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum
To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5394654/metavia-inc-nasdaq-mtva?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC
Request a one-on-one meeting: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76
HH Kim, CEO and President, presents for MetaVia, alongside CFO Marshall H. Woodworth. Kim previously served as General Counsel and Senior Vice President of Dong-A ST and Dong-A Socio Group, while Woodworth brings more than 35 years in financial roles, including over 20 years across life sciences and related sectors.
MetaVia is a clinical-stage biotechnology company focused on cardiometabolic diseases. Its lead candidate, DA-1726, is a novel oxyntomodulin analogue functioning as a dual GLP-1 and glucagon receptor agonist in development for obesity, which demonstrated best-in-class potential for weight loss, glucose control, and waist circumference reduction in a Phase 1 trial. The company is also developing vanoglipel (DA-1241), a GPR119 agonist, for metabolic dysfunction-associated steatohepatitis (MASH).
Learn more at https://ir.metaviatx.com/.
Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com.
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com.
B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
